Wockridge Pharma Private Limited
About Wockridge Pharma Private Limited
Data last updated:
Wockridge Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 13 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2018PTC122935.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sowjanya Tamma and Rajasekhara Reddy Tamma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.4 – 32 – 121 Phase – 1 Near Ramalayam Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.05 Lakh, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹89,282 (net margin 4.5%) and EBITDA of ₹1.26 Lakh (EBITDA margin 6.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No.4 – 32 – 121 Phase – 1 Near Ramalayam Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wockridge Pharma Private Limited
The main business activity of Wockridge Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wockridge Pharma Private Limited FY 2025 filings available
Wockridge Pharma Private Limited reported revenue of ₹20.05 Lakh (up 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Wockridge Pharma Private Limited
Revenue rose 66% in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wockridge Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.26 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹89,282 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wockridge Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wockridge Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wockridge Pharma Private Limited
Wockridge Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zeinix Labs India Private Limited | ₹20.22 Lakh (FY 2021) | •••• | •••• | 2596.0% | •••• | Bangalore, Karnataka, India |
| Sphere India Tanyakta Nirman Seva Private Limited | ₹20.22 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Noida, Uttar Pradesh, India |
| Edumark Softech Private Limited | ₹20.2 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Manbio 360 Private Limited | ₹20.15 Lakh (FY 2024) | •••• | •••• | -23.0% | •••• | Bangalore, Karnataka, India |
| Association for Socially Applicable Research | ₹20.06 Lakh (FY 2025) | •••• | •••• | 5826.0% | •••• | Pune, Maharashtra, India |
| Wockridge Pharma Private Limited this company | ₹20.05 Lakh (FY 2025) | •••• | •••• | 66.0% | •••• | Hyderabad, Telangana, India |
| Kaiza Health Private Limited | ₹20.03 Lakh (FY 2024) | •••• | •••• | 100.0% | •••• | Bangalore, Karnataka, India |
| Anavil Pharmaceuticals Private Limited | ₹20.01 Lakh (FY 2025) | •••• | •••• | 751.0% | •••• | Jalgaon, Maharashtra, India |
| Samudhyoga Waste Chakra Private Limited | ₹20 Lakh (FY 2024) | •••• | •••• | 56.0% | •••• | Chennai, Tamil Nadu, India |
| Vortech Private Limited | ₹20 Lakh (FY 2020) | •••• | •••• | 39725.0% | •••• | Ahmedabad, Gujarat, India |
| Kirhe Energy Saving Service Private Limited | ₹19.99 Lakh (FY 2020) | •••• | •••• | 39.0% | •••• | Porvorim, Goa, India |
Peers are the five companies nearest above and the five nearest below Wockridge Pharma by revenue in the same principal business activity (Scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Wockridge Pharma Private Limited
Wockridge Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sowjanya Tamma | Director | 13 Mar 2018 | 8 Years 6 Months | Current |
| Rajasekhara Reddy Tamma | Director | 13 Mar 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of Wockridge Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wockridge Pharma Private Limited
Wockridge Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wockridge Pharma Private Limited
Employment history and EPFO contributions of people linked to Wockridge Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wockridge Pharma Private Limited
Wockridge Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Rajasekhara Reddy Tamma was appointed as Director on 13 Mar 2018.
Credit Ratings, Litigation & Regulatory Alerts for Wockridge Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wockridge Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wockridge Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wockridge Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wockridge Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wockridge Pharma Private Limited
Wockridge Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in science research, within the research and development industry. It was incorporated on 13 March 2018 (8+ years old) and is registered under CIN U73100TG2018PTC122935.
Wockridge Pharma reported revenue of ₹20.05 Lakh for FY 2025 (up 66% YoY).
Wockridge Pharma has 2 current directors:
- Sowjanya Tamma - Director
- Rajasekhara Reddy Tamma - Director
Wockridge Pharma reported a net profit of ₹89,282 (net margin 4.5%) and EBITDA of ₹1.26 Lakh (EBITDA margin 6.3%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Wockridge Pharma is U73100TG2018PTC122935. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wockridge Pharma was incorporated on 13 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Wockridge Pharma by revenue are Zeinix Labs India Private Limited, Sphere India Tanyakta Nirman Seva Private Limited, Edumark Softech Private Limited, Manbio 360 Private Limited, Association for Socially Applicable Research and 5 more, all in the same principal business activity (Scientific research and development).
Rajasekhara Reddy Tamma was appointed as Director on 13 Mar 2018. Sowjanya Tamma was appointed as Director on 13 Mar 2018.
The registered office of Wockridge Pharma is at H.No.4 – 32 – 121 Phase – 1 Near Ramalayam Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Wockridge Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Wockridge Pharma operates in the research and development industry, in the science research segment.